NCT00103402 - Trial to Compare Alfuzosin Versus Placebo in the Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome | Biotech Hunter

Enrollment

272

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions

Prostatitis

Interventions

DRUG

Alfuzosin

DRUG

Placebo

Trial Locations (10)

Temple University, Philadelphia

University of Maryland, Baltimore

University of Mississippi Medical Center, Jackson

Cleveland Clinic, Cleveland

Northwestern U. Feinberg School of Medicine, Chicago

David Geffen School of Medicine at UCLA, Los Angeles

Stanford University Medical Center, Stanford

University of Washington- Harborview Medical Center, Seattle

Harvard Medical School- Massachusetts General Hospital, Boston

Queen's University, Kingston

All Listed Sponsors

collaborator

University of Pennsylvania

OTHER

lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH